CDC study: no evidence for teratogenicity of Bendectin.
D000014:Abnormalities, Drug-Induced / Q000209:etiology*; D000932:Antiemetics / Q000009:adverse effects*; D004025:Dicyclomine; D004319:Doxylamine / Q000009:adverse effects*; D004338:Drug Combinations; D005260:Female; D006330:Heart Defects, Congenital / Q000139:chemically induced*; D006801:Humans; D006939:Hyperemesis Gravidarum / Q000188:drug therapy*; D009325:Nausea / Q000517:prevention & control; D011247:Pregnancy; D011725:Pyridines / Q000009:adverse effects*; D011736:Pyridoxine / Q000009:adverse effects*; D014839:Vomiting / Q000517:prevention & control
D000932:Antiemetics; D004338:Drug Combinations; D011725:Pyridines; C004454:dicyclomine, doxylamine, pyridoxine drug combination; D004025:Dicyclomine; D004319:Doxylamine; D011736:Pyridoxine